Welcome to our dedicated page for Trueblue SEC filings (Ticker: TBI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TrueBlue, Inc. filings document the public-company disclosures of a specialized workforce solutions provider whose common stock trades on the New York Stock Exchange under TBI. Its Form 8-K reports cover quarterly results, Regulation FD materials, material agreements, financing arrangements, executive appointments and governance-related communications.
TrueBlue proxy and related filings describe annual meeting matters, board governance, compensation and shareholder voting procedures. Recent filings also document amendments to the company’s credit agreement, stockholder rights arrangements, the expiration and withdrawal from listing of preferred stock purchase rights, and solicitation materials connected to shareholder engagement and board matters.
TrueBlue, Inc. director Jeffrey B. Sakaguchi reported an equity award on Common Stock. He acquired 35,733 restricted stock units at a stated price of $0.00 per share, increasing his directly held stake to 124,443 shares after the transaction. The restricted stock units will be settled one-for-one in Common Stock and vest in full one year from the grant date.
TrueBlue, Inc. director William J. Seward reported an equity compensation grant of 27,566 shares of Common Stock on February 20, 2026. The filing describes this as an acquisition through a grant or award, with no cash price per share reported.
A footnote explains the award is in the form of restricted stock units that will settle into Common Stock on a one-for-one basis in the future. These restricted stock units are scheduled to vest in full one year from the grant date, and Seward’s directly held stake after the grant is 27,566 shares.
TrueBlue, Inc. director William C. Goings reported an equity award of 29,607 shares of Common Stock in the form of restricted stock units. These units vest in full one year from the grant date and will be settled one-for-one in shares after he leaves the Board.
Following this award, his reported holdings total 85,000 shares, which the footnotes state are deferred under the company’s Equity Retainer and Deferred Compensation Plan for Non-Employee Directors. The award has no cash exercise price and represents additional long-term, stock-based compensation.
Greenblatt William reported acquisition or exercise transactions in this Form 4 filing.
TrueBlue, Inc. director William Greenblatt reported an equity award of 27,566 shares of common stock, received as a grant of restricted stock units at no cash cost. The units will be settled one-for-one in common shares and vest in full one year after the grant date.
TrueBlue, Inc. director Sonita Lontoh acquired an equity award through a Form 4 filing. She received 27,566 restricted stock units of TrueBlue common stock as a grant, with no cash paid per share. These units will be settled one-for-one in common shares and vest in full one year from the grant date. After this award, her reported direct holdings total 74,919 shares of common stock.
TrueBlue, Inc. director Kristi A. Savacool reported an equity award of 27,566 shares of Common Stock, received as a grant of restricted stock units at no cash cost to her. These units will convert into shares on a one-for-one basis.
The restricted stock units vest in full one year from the grant date, with delivery of the vested shares scheduled 90 days after her separation from service on the Board. Following this award, she reports direct beneficial ownership of 89,536 shares, including 82,940 shares deferred under the company’s director compensation plan.
Kreidler Robert C. reported acquisition or exercise transactions in this Form 4 filing.
TrueBlue, Inc. director Robert C. Kreidler reported an equity award of 27,566 shares of common stock in the form of restricted stock units. These units will vest in full one year from the grant date and will be settled on a one-for-one basis in common shares.
Delivery of the vested shares to Kreidler will occur 90 days after his separation from service on the Board of Directors. Following this award, his directly held and deferred holdings total 85,381 shares, including 71,664 shares deferred under the company’s Equity Retainer and Deferred Compensation Plan for Non-Employee Directors.
Jones Kim Harris reported acquisition or exercise transactions in this Form 4 filing.
TrueBlue, Inc. director Kim Harris Jones reported an equity award of 29,607 shares of common stock in the form of restricted stock units. These units will vest in full one year from the grant date and will be settled on a one-for-one basis into common shares.
After this grant, her directly held and deferred holdings total 100,060 shares, including 94,719 shares deferred under TrueBlue’s Equity Retainer and Deferred Compensation Plan for Non-Employee Directors. Vested shares from this award will be delivered 90 days after her separation from the Board.
TrueBlue, Inc. director Colleen B. Brown reported an equity award of 29,097 shares of Common Stock at a stated price of $0.00 per share. A footnote explains this represents a grant of restricted stock units that will convert into shares on a one-for-one basis and vest in full one year from the grant date. Following this award, her directly held Common Stock balance is 89,112 shares.
TrueBlue, Inc. outlines its role as a specialized workforce solutions provider and key risks facing the business. In fiscal 2025, the company connected approximately 291,000 people with work and served about 53,000 clients across construction, logistics, retail, hospitality, healthcare and other sectors.
Operations are organized into three segments: PeopleReady for on-demand and skilled trades staffing, PeopleManagement for on‑site industrial and driver solutions, and PeopleSolutions for recruitment process outsourcing, managed service provider programs and healthcare staffing. Strategy for fiscal 2026 focuses on strengthening sales, expanding in high‑growth and less cyclical end markets (including healthcare and skilled trades), and accelerating technology such as JobStack, Stafftrack and the Affinix platform.
The filing highlights extensive risk factors, including economic cyclicality, technology disruption and AI, workers’ compensation costs, client concentration, integration of acquisitions such as Healthcare Staffing Professionals, Inc., regulatory and tax changes, cybersecurity and data privacy exposures, and the need to attract and retain employees and contingent associates.